3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Plasma Cell
1
HIV Infections
1
Disease
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Radiotherapy, Conformal
2
Radiotherapy
2
Paclitaxel
2
Carboplatin
2
veliparib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Platinum
1
Nivolumab
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cisplatin
1
CTLA-4 Antigen
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Bronchiolo-Alveolar
×
Fluorodeoxyglucose F18
×
30 days
×
Clear all
No trials found.